<DOC>
	<DOCNO>NCT02617537</DOCNO>
	<brief_summary>The objective study investigate safety efficacy ( 0.02 mg EE betadex clathrate [ β-CDC ] ) / 3 mg drospirenone ( DRSP ) dysmenorrhea . In order appropriately evaluate efficacy EE ( β-CDC ) /DRSP study set placebo-controlled comparative study</brief_summary>
	<brief_title>To Investigate Efficacy YAZ Treatment Dysmenorrhea</brief_title>
	<detailed_description />
	<mesh_term>Dysmenorrhea</mesh_term>
	<criteria>Patients suffer dysmenorrhea least previous 3 month prior Visit 1 minimum visual analogue scale ( VAS ) score 30 mm regard pain menstrual period screen period Good general health ( except finding relate dysmenorrhea ) proven medical history Patients age 18 year old time obtain informed consent ; smoker must older 35 year time point inform consent Normal clinically insignificant cervical smear require follow ( cervical smear take screen visit normal result document within previous six month ) . Human papilloma virus ( HPV ) test subject atypical squamous cell undetermined significance ( ASCUS ) use adjunctive test . Subjects ASCUS include negative highrisk HPV strain ( HPV 16 , HPV18 ) . Women childbearing potential must agree adequate contraception use sexually active . This apply sign inform consent form 2 week last study drug administration . Pregnancy ( confirm suspect ) lactation ( less three month since delivery , abortion , lactation start treatment ) Patients wish become pregnant course study Body Mass Index ( BMI ) &gt; 32 kg/m2 Hypersensitivity ingredient study drug Laboratory value outside inclusion range randomization Any diseases condition compromise function body system could result altered absorption , excessive accumulation , impaired metabolism , alter excretion study medication Any diseases condition might interfere conduct study interpretation result Any disease condition may worsen hormonal treatment accord assessment opinion investigator .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>